COMPARISON OF THE INTRACELLULAR PHARMACOKINETICS OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN PATIENTS WITH ACUTE-LEUKEMIA

被引：0
|
作者：
TIDEFELT, U
SUNDMANENGBERG, B
PAUL, C
机构：
[1] HUDDINGE HOSP,DEPT MED,DIV CLIN HEMATOL & ONCOL,S-14146 HUDDINGE,SWEDEN
[2] KAROLINSKA INST,S-14186 HUDDINGE,SWEDEN
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1989年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：225 / 229
页数：5
相关论文
共 50 条
  • [1] PHASE-II STUDY OF 4'EPI-DOXORUBICIN IN ACUTE-LEUKEMIA
    ESTEY, E
    KEATING, M
    MCCREDIE, K
    BODEY, G
    WALTERS, R
    FREIREICH, EJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 118 - 118
  • [2] CROSSOVER STUDY OF PHARMACOKINETICS AND HEMATOLOGICAL TOXICITY OF 4'-EPI-DOXORUBICIN AND DOXORUBICIN IN CANCER-PATIENTS
    MARTINI, A
    MORO, E
    PACCIARINI, MA
    TAMASSIA, V
    NATALE, N
    PIAZZA, E
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1984, 4 (03) : 231 - 238
  • [3] PHARMACOKINETICS AND CENTRAL HEMODYNAMIC-EFFECTS OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN THE PIG
    ANDERSSON, M
    DOMELLOF, L
    EKSBORG, S
    HAGGMARK, S
    JOHANSSON, G
    REIZ, S
    HERSLOF, A
    ACTA ONCOLOGICA, 1989, 28 (05) : 709 - 714
  • [4] PHARMACOKINETICS OF EPI-DOXORUBICIN AND DOXORUBICIN IN BREAST-CANCER PATIENTS - A CROSSOVER STUDY
    MROSS, K
    MAESSEN, P
    VANDERVIJGH, WJF
    GALL, H
    BOVEN, E
    PINEDO, HM
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 114 - 114
  • [5] PHARMACOKINETICS OF 4'EPI-DOXORUBICIN AFTER INTRAVENOUS AND INTRAVESICAL ADMINISTRATION
    VANDERVIJGH, WJF
    WEENEN, H
    OSTEROP, A
    VANDERPOORT, SEJM
    KURTH, KK
    BOGDANOWICZ, JF
    PINEDO, HM
    BRITISH JOURNAL OF CANCER, 1985, 52 (03) : 463 - 464
  • [6] DOXORUBICIN (DXR) AND 4'-EPI-DOXORUBICIN (4EDXR) - CLINICAL-EXPERIENCE AND PHARMACOKINETICS
    MARTONI, A
    DIMARCO, AR
    CAMAGGI, CM
    STROCCHI, E
    FRUET, F
    MARRARO, D
    GIOVANNINI, M
    TOMASI, L
    PACCIARINI, MA
    PANNUTI, F
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1983, 9 (11) : 767 - 774
  • [7] A comparative pharmacokinetic study of doxorubicin and 4′-epi-doxorubicin in children with acute lymphocytic leukemia using a limited sampling procedure
    Eksborg, S
    Palm, C
    Björk, O
    ANTI-CANCER DRUGS, 2000, 11 (02) : 129 - 136
  • [8] TOXIC AND THERAPEUTIC ACTIVITY OF 4'-EPI-DOXORUBICIN
    BONFANTE, V
    VILLANI, F
    BONADONNA, G
    TUMORI JOURNAL, 1982, 68 (02): : 105 - 111
  • [9] 4' EPI-DOXORUBICIN IN LEUKEMIA AND LYMPHOMA (A PRELIMINARY CLINICAL-TRIAL)
    ERIDANI, S
    KUBIE, A
    LUNGU, F
    BRITISH JOURNAL OF CANCER, 1982, 46 (03) : 500 - 500
  • [10] CLINICAL TOXICITY OF 4'-EPI-DOXORUBICIN (EPIRUBICIN)
    GANZINA, F
    DIPIETRO, N
    MAGNI, O
    TUMORI, 1985, 71 (03) : 233 - 240
12345